Organized by DBT SAHAJ Mass Spectrometry Core Facility, BRIC-Rajiv Gandhi Centre for Biotechnology
"Bringing together leading experts to explore the power of mass spectrometry-driven proteomics, metabolomics, and lipidomics in advancing disease biology and transforming lives."
The 2nd National Symposium on "Mass Spectrometry-Based Omics in Disease Biology" (NSMS 2027) provides an extraordinary platform uniting leading scientists, clinicians, academicians, and industry pioneers.
Our core objective is to catalyze breakthrough discoveries in high-resolution mass spectrometry, biomarker identification, translational medicine, and precision diagnostics while cultivating high-impact interdisciplinary collaborations.
BRIC-Rajiv Gandhi Centre for Biotechnology
Thycaud Post, Poojappura,
Thiruvananthapuram - 695 014,
Kerala, India
The symposium will be hosted at the BRIC–Rajiv Gandhi Centre for Biotechnology (BRIC–RGCB), a premier national research institution dedicated to advancing biotechnology and biomedical research.
Accommodation: ₹500 per night (twin-sharing), payable separately at the Guest House. Subject to availability and must be selected during online registration.
Financial assistance for selected student abstracts
Best Oral & Poster Presentation Honors
Opportunities for students and research scholars to present their work and compete for Best Oral and Best Poster Presentation Awards.
Travel awards will be provided to selected abstracts to support the participation of deserving student researchers at NSMS 2027.
The symposium is intended for a diverse audience of students, research scholars, postdoctoral fellows, faculty members, scientists, clinicians, bioinformaticians, and industry professionals working at the interface of mass spectrometry, omics, and disease biology.
The programme will particularly benefit researchers involved in proteomics, phosphoproteomics, metabolomics, lipidomics, glycomics, biomarker discovery, clinical and translational research, precision medicine, bioinformatics, and systems biology. Participation is also encouraged from mass spectrometry core facilities, analytical laboratories, pharmaceutical and biotechnology industries, and researchers seeking to establish or strengthen MS-based omics capabilities.
